- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06065072
Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
This is a prospective comparative study that will be conducted at one clinical site in the United States, in which subjects who sign an informed consent form and fulfil all inclusion and exclusion criteria, will have OCT scans obtained using the test and the predicate devices.
There will be two main types of analyses performed as part of this study, including 1) a precision analysis, and 2) an agreement analysis.
The precision analyses will be conducted utilizing all complete complements of acceptable scans from the test devices and predicate device for each of the 3 configurations. A complete complement of acceptable scans can be defined as subjects having 3 acceptable replicate scans on each of the 3 devices, at each of the 3 configurations. This is also synonymous with 3 scans for each of the 3 configurations on all 3 devices. If subjects have more than 3 acceptable scans per configuration on a device, only the first 3 will be considered for analyses.
The agreement analysis will be conducted utilizing the first set of acceptable scans from each instrument for all overlapping measurement types (for all measurement types two or more of the devices have in common) related to performance endpoints.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Deep Soni
- Phone Number: 857-250-9178
- Email: deep@neeraeye.com
Study Locations
-
-
Massachusetts
-
Woburn, Massachusetts, United States, 01801
- Recruiting
- NorthEast Eye Research Associates
-
Contact:
- Deep Soni
- Phone Number: 857-250-9178
- Email: deep@neeraeye.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria - Normal Cohort:
- Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
- Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
- Subjects who agree to participate in the study.
Inclusion Criteria - Cataract Cohort:
- Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
- Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
- Subjects who agree to participate in the study;
- Subjects diagnosed with cataract classified per the LOCS III scale.
Inclusion Criteria - Special Eyes Cohort (eyes without a natural lens or eyes containing artificial materials):
- Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
- Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
- Subjects who agree to participate in the study;
- Subjects diagnosed with one or both eyes having aphakia, pseudophakia or silicone oil.
Exclusion Criteria - Normal Cohort:
- Subjects unable to tolerate ophthalmic imaging;
- Subjects who did not take off their contact lenses earlier than 15 minutes prior to the study;
- Subjects with any current ocular pathology, as determined by self-report and confirmed by the investigator assessment and/or confirmed by the investigator assessment at the study visit;
- Subjects that present with an active ocular infection in either eye;
- Subjects who have a history of ocular surgery, including laser therapy/surgery;
- Subjects with a condition or in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Exclusion Criteria - Cataract Cohort:
- Subjects unable to tolerate ophthalmic imaging;
- Subjects who did not take off their contact lenses earlier than 15 minutes prior to the study;
- Subjects with corneal or conjunctival abnormalities that may affect adequate assessment of the anterior chamber in either eye;
- Subjects that present with an active ocular infection in either eye;
- Subjects who have a history of ocular surgery, including laser therapy/surgery;
- Subjects with a condition or in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Exclusion Criteria - Special Eyes Cohort (eyes without a natural lens or eyes containing artificial materials):
- Subjects unable to tolerate ophthalmic imaging;
- Subjects who did not take off their contact lenses earlier than 15 minutes prior to the study;
- Subjects with corneal or conjunctival abnormalities that may affect adequate assessment of the anterior chamber in either eye;
- Subjects that present with an active ocular infection in either eye;
- Subjects with a condition or in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study;
- Subjects with evidence of silicone oil emulsification;
- Subjects with silicone oil in the anterior chamber;
- Subjects with adherence of oil droplets to an intraocular lens.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Normal
|
Optical measurements by optical biometers and an OCT
|
Cataract
|
Optical measurements by optical biometers and an OCT
|
Special eye
|
Optical measurements by optical biometers and an OCT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Agreement between the test devices and predicate device
Time Frame: Through study completion, approximately 4 months
|
Agreement between each of the test devices and the predicate device will be evaluated by the mean difference and SD, the 95% limits of agreement (LOA), the Bland-Altman plots, and Deming regression for each subject population.
|
Through study completion, approximately 4 months
|
Precision of the test devices
Time Frame: Through study completion, approximately 4 months
|
A crossed two-way random-effects analysis of variance (ANOVA) model will be used to estimate the repeatability and reproducibility limits of each scan parameter by subject population and study device (test and predicate device).
This ANOVA model will include the configuration, subject, and interaction between configuration and subject as the factors.
Repeatability and reproducibility standard deviations, as well as the corresponding coefficient of variations (CVs), will be calculated using this ANOVA model.
|
Through study completion, approximately 4 months
|
Safety of the test devices
Time Frame: Through study completion, approximately 4 months
|
Adverse events reported will be listed by subject.
|
Through study completion, approximately 4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ioanis Panagiotopoulos, Dr., NorthEast Eye Research Associates
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Tomey OA-2000-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on Optical measurement
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedInfant DevelopmentUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompleted
-
Mahidol UniversityCompleted
-
Akdeniz UniversityTerminated
-
G. d'Annunzio UniversityUnknownNormal Foveal ThicknessItaly
-
PulseOn OyTAYS Sydänkeskus Oy; Atostek OyCompleted
-
Kahramanmaras Sutcu Imam UniversityCompletedEye Manifestations | Tobacco; Use, Harmful | Tobacco Chewing ToxicityTurkey
-
Medical University of ViennaWithdrawn
-
Seoul National University HospitalUnknownCoronary Artery DiseaseKorea, Republic of
-
ASST Fatebenefratelli SaccoCompletedPneumoperitoneum | Intracranial Hypertension | Brain Edema | Surgery, LaparoscopicItaly